Imaging of prion diseases

被引:26
|
作者
Letourneau-Guillon, Laurent [1 ]
Wada, Ryan [2 ]
Kucharczyk, Walter [1 ]
机构
[1] Univ Toronto, Univ Hlth Network, Dept Diagnost Imaging, Toronto, ON M5G 1X8, Canada
[2] Radiol Consultants Associated, Calgary, AB, Canada
关键词
Creutzfeldt-Jakob disease; prion; MRI; diffusion-weighted imaging; dementia; CREUTZFELDT-JAKOB-DISEASE; DIFFUSION-WEIGHTED MRI; POSITRON-EMISSION-TOMOGRAPHY; PULVINAR SIGN; 14-3-3; PROTEIN; SPORADIC CJD; CEREBROSPINAL-FLUID; DIAGNOSTIC-CRITERIA; CLINICAL-DIAGNOSIS; HEIDENHAIN VARIANT;
D O I
10.1002/jmri.23504
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Prion diseases are caused by self-replicating proteins that induce lethal neurodegenerative disorders. In the last decade, the understanding of the different clinical, pathological, and neuroimaging phenotypes of this group of disorders has evolved paralleling the advances in prion molecular biology. From an imaging standpoint, the implementation of diffusion-weighted imaging in routine practice has markedly facilitated the detection of prion diseases, especially Creutzfeldt-Jakob. Less frequent prion-related disorders, including genetic diseases, may also benefit from progresses in the field of quantitative diffusion-weighted imaging, MR spectroscopy or molecular imaging. Herein, we present a review of the neuroimaging features of the prion disorders known to affect humans emphasizing the important contribution of MRI in the diagnosis of this group of disorders. J. Magn. Reson. Imaging 2012;. (c) 2011 Wiley Periodicals, Inc.
引用
收藏
页码:998 / 1012
页数:15
相关论文
共 50 条
  • [31] Translational Research in Alzheimer's and Prion Diseases
    Di Fede, Giuseppe
    Giaccone, Giorgio
    Salmona, Mario
    Tagliavini, Fabrizio
    JOURNAL OF ALZHEIMERS DISEASE, 2018, 62 (03) : 1247 - 1259
  • [32] The end of the BSE saga: do we still need surveillance for human prion diseases?
    Budka, Herbert
    Will, Robert G.
    SWISS MEDICAL WEEKLY, 2015, 145
  • [33] Unmet needs of biochemical biomarkers for human prion diseases
    Hermann, Peter
    Zerr, Inga
    PRION, 2024, 18 (01) : 89 - 93
  • [34] Role of Biomarkers for the Diagnosis of Prion Diseases: A Narrative Review
    Altuna, Miren
    Ruiz, Inigo
    Zelaya, Maria Victoria
    Mendioroz, Maite
    MEDICINA-LITHUANIA, 2022, 58 (04):
  • [35] Evaluation of a New Criterion for Detecting Prion Disease With Diffusion Magnetic Resonance Imaging
    Bizzi, Alberto
    Pascuzzo, Riccardo
    Blevins, Janis
    Grisoli, Marina
    Lodi, Raffaele
    Moscatelli, Marco E. M.
    Castelli, Gianmarco
    Cohen, Mark L.
    Schonberger, Lawrence B.
    Foutz, Aaron
    Safar, Jiri G.
    Appleby, Brian S.
    Gambetti, Pierluigi
    JAMA NEUROLOGY, 2020, 77 (09) : 1141 - 1149
  • [36] Protein misfolding and prion diseases
    Cohen, FE
    JOURNAL OF MOLECULAR BIOLOGY, 1999, 293 (02) : 313 - 320
  • [37] Infectious and Sporadic Prion Diseases
    Knight, Richard
    PRION PROTEIN, 2017, 150 : 293 - 318
  • [38] Prion Diseases and Their Biochemical Mechanisms
    Cobb, Nathan J.
    Surewicz, Witold K.
    BIOCHEMISTRY, 2009, 48 (12) : 2574 - 2585
  • [39] Prion diseases, always a threat?
    Saitoh, Yuji
    Mizusawa, Hidehiro
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2024, 463
  • [40] Prion diseases and blood transfusion
    Beauvais, P
    de Villemeur, TB
    TRANSFUSION CLINIQUE ET BIOLOGIQUE, 1999, 6 (01) : 24 - 28